Zoetis Inc. (ZTS) DCF Valuation

Zoetis Inc. (ZTS) DCF Valuation

US | Healthcare | Drug Manufacturers - Specialty & Generic | NYSE
Zoetis Inc. (ZTS) DCF Valuation

Fully Editable: Tailor To Your Needs In Excel Or Sheets

Professional Design: Trusted, Industry-Standard Templates

Investor-Approved Valuation Models

MAC/PC Compatible, Fully Unlocked

No Expertise Is Needed; Easy To Follow

Zoetis Inc. (ZTS) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Designed for accuracy, our Zoetis Inc. (ZTS) DCF Calculator enables you to evaluate Zoetis Inc. valuation using real-world financial data, offering complete flexibility to modify all key parameters for enhanced projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020
AY2
2021
AY3
2022
AY4
2023
AY5
2024
FY1
2025
FY2
2026
FY3
2027
FY4
2028
FY5
2029
Revenue 6,675.0 7,776.0 8,080.0 8,544.0 9,256.0 10,053.9 10,920.5 11,861.8 12,884.3 13,994.9
Revenue Growth, % 0 16.49 3.91 5.74 8.33 8.62 8.62 8.62 8.62 8.62
EBITDA 2,686.0 3,172.0 3,358.0 3,685.0 3,855.0 4,169.7 4,529.2 4,919.6 5,343.6 5,804.3
EBITDA, % 40.24 40.79 41.56 43.13 41.65 41.47 41.47 41.47 41.47 41.47
Depreciation 441.0 448.0 465.0 491.0 497.0 587.9 638.6 693.7 753.5 818.4
Depreciation, % 6.61 5.76 5.75 5.75 5.37 5.85 5.85 5.85 5.85 5.85
EBIT 2,245.0 2,724.0 2,893.0 3,194.0 3,358.0 3,581.8 3,890.5 4,225.9 4,590.2 4,985.8
EBIT, % 33.63 35.03 35.8 37.38 36.28 35.63 35.63 35.63 35.63 35.63
Total Cash 3,602.0 3,482.0 3,577.0 2,039.0 1,985.0 3,786.7 4,113.1 4,467.7 4,852.8 5,271.1
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 1,013.0 1,133.0 1,215.0 1,304.0 1,316.0
Account Receivables, % 15.18 14.57 15.04 15.26 14.22
Inventories 1,628.0 1,923.0 2,345.0 2,564.0 2,306.0 2,675.6 2,906.3 3,156.8 3,428.9 3,724.5
Inventories, % 24.39 24.73 29.02 30.01 24.91 26.61 26.61 26.61 26.61 26.61
Accounts Payable 457.0 436.0 405.0 411.0 433.0 542.0 588.7 639.5 694.6 754.4
Accounts Payable, % 6.85 5.61 5.01 4.81 4.68 5.39 5.39 5.39 5.39 5.39
Capital Expenditure -453.0 -477.0 -586.0 -732.0 -655.0 -720.2 -782.3 -849.7 -923.0 -1,002.5
Capital Expenditure, % -6.79 -6.13 -7.25 -8.57 -7.08 -7.16 -7.16 -7.16 -7.16 -7.16
Tax Rate, % 20.65 20.65 20.65 20.65 20.65 20.65 20.65 20.65 20.65 20.65
EBITAT 1,842.3 2,230.2 2,302.6 2,550.0 2,664.5 2,884.9 3,133.6 3,403.7 3,697.1 4,015.8
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -353.7 1,765.2 1,646.6 2,007.0 2,774.5 2,314.7 2,677.3 2,908.0 3,158.7 3,431.0
WACC, % 8.05 8.05 8.05 8.05 8.04 8.05 8.05 8.05 8.05 8.05
PV UFCF
SUM PV UFCF 11,388.2
Long Term Growth Rate, % 4.00
Free cash flow (T + 1) 3,568
Terminal Value 88,125
Present Terminal Value 59,841
Enterprise Value 71,229
Net Debt 4,759
Equity Value 66,470
Diluted Shares Outstanding, MM 455
Equity Value Per Share 146.14

What You Will Get

  • Real ZTS Financials: Access to both historical and forecasted data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
  • Scenario Analysis: Explore various scenarios to assess Zoetis' future performance.
  • User-Friendly Design: Designed for professionals while remaining approachable for newcomers.

Key Features

  • Comprehensive Historical Data: Zoetis Inc.'s financial statements and pre-filled projections.
  • Customizable Parameters: Adjust WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Valuation: Instantly view Zoetis Inc.'s intrinsic value updates.
  • Intuitive Visualizations: Dashboard graphs illustrate valuation outcomes and essential metrics.
  • Designed for Precision: A reliable resource for analysts, investors, and finance professionals.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Zoetis Inc. (ZTS) data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Zoetis Inc. (ZTS) intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for Zoetis Inc. (ZTS)?

  • Accuracy: Utilizes real Zoetis financial data for precise calculations.
  • Flexibility: Allows users to easily test and adjust inputs as needed.
  • Time-Saving: Avoid the complexities of creating a DCF model from the ground up.
  • Professional-Grade: Crafted with the expertise and precision expected at the CFO level.
  • User-Friendly: Intuitive interface designed for users of all financial backgrounds.

Who Should Use This Product?

  • Investors: Assess Zoetis Inc.'s (ZTS) valuation before making stock transactions.
  • CFOs and Financial Analysts: Enhance valuation workflows and evaluate financial forecasts.
  • Startup Founders: Discover how leading public companies like Zoetis Inc. (ZTS) are appraised.
  • Consultants: Provide comprehensive valuation reports for your clientele.
  • Students and Educators: Utilize real-time data to practice and instruct on valuation strategies.

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Zoetis Inc. (ZTS) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Zoetis Inc. (ZTS).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.